PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Nov-2024 PUSHING 2PP BOUNDARIES: NEW NANOONE GREEN INTRODUCES 515 NM LASER CAPABILITY UpNano GmbH
11-Nov-2024 Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers Gilead Sciences Ltd
11-Nov-2024 SMC recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
11-Nov-2024 Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Autolus Therapeutics
11-Nov-2024 Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma Johnson & Johnson
11-Nov-2024 ACG Inspection launches Life Sciences Cloud ACG Inspection
11-Nov-2024 Moberg Pharma’s Nomination Committee appointed Moberg Pharma
11-Nov-2024 Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Relief Therapeutics Holding SA
08-Nov-2024 SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR Cheplapharm AG
07-Nov-2024 Cherwell highlighting microbiology EM products at Pharmaceutical Microbiology Conference Cherwell
07-Nov-2024 The Accumulus Platform Powers Sanofi’s Submissions to Multiple Regulators Around the World Accumulus Synergy, Inc.
07-Nov-2024 CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 CureVac
07-Nov-2024 Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update Immunic AG
07-Nov-2024 New ultrasonic air bubble de-tector 300 µm AD-102 AMSYS
07-Nov-2024 Bristol Myers Squibb Creates New Leadership Role, Appointing Karen Costello as General Manager for Ireland Bristol Myers Squibb
07-Nov-2024 Genmab Announces Financial Results for the First Nine Months of 2024 Genmab
07-Nov-2024 RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed   RHÖN-KLINIKUM Aktiengesellschaft
07-Nov-2024 Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth Cantourage Group SE
07-Nov-2024 APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted APONTIS PHARMA AG
06-Nov-2024 aap informs about the actual status of the mandatory convertible bond 2023-2028 aap Implantate AG